BUPACURE-150(Tablet)


 MRP-180/-


BUPACURE-150

Bupropion 150mg tablet


1. Introduction

Drug Class: Atypical antidepressant

Unique Feature:

Unlike SSRIs, it works mainly on dopamine   

         and norepinephrine.

Effective in both depression and smoking      

         cessation therapy.

2. Mechanism of Action

Acts as a Norepinephrine-Dopamine 

          Reuptake Inhibitor (NDRI).

Increases dopamine and norepinephrine 

        levels in the brain.

Has no significant direct effect on 

         serotonin (unlike SSRIs).

Benefits:

Improves mood and energy.

Enhances focus and motivation.

Reduces nicotine craving and

                withdrawal symptoms.

3. Pharmacokinetics

Absorption: Well absorbed orally.

Metabolism: Primarily by the liver (CYP2B6

                                enzyme).

Half-life: ~21 hours (supports once or twice

                          daily dosing).

Excretion: Mainly through urine.



4. Indications 

1. Major Depressive Disorder (MDD)

2. Seasonal Affective Disorder (SAD) – 

        depression during winter months.

3. Smoking cessation therapy – reduces 

        craving and withdrawal.

4. Off-label uses:

Attention-Deficit/Hyperactivity Disorder 

        (ADHD)

Obesity (as it does not cause weight gain)

Sexual dysfunction (especially SSRI-induced

        sexual dysfunction)



5. Dosage

For depression:

Start with 150 mg once daily (SR/XL 

        formulation).

Gradually increase to 300–450 mg/day 

        (divided doses).


For smoking cessation:

150 mg once daily for 3 days, then 150 mg

         twice daily.

Quit date should be set 1–2 weeks after 

         starting therapy.



6. Adverse Effects

Common:

Insomnia

Headache

Dry mouth

Anxiety, restlessness


 Serious (rare but important):

Seizures (dose-dependent risk, especially

        >450 mg/day)

Hypertension

Agitation, mood changes



7. Drug Interactions

 Alcohol: Increases seizure risk.

 MAO inhibitors: Contraindicated (at least 14-

  day washout needed).

 Drugs affecting CYP2B6 metabolism 

 (inhibitors or inducers) may require dose 

  adjustments.



8. Contraindications

History of seizure disorder or predisposition to 

   seizures.

 Eating disorders (Anorexia nervosa, Bulimia 

   nervosa).

 Patients undergoing abrupt alcohol or 

   benzodiazepine withdrawal.

 Severe hepatic impairment.



9. Advantages

Does not cause weight gain (unlike many 

   antidepressants).

 Less sexual dysfunction compared to SSRIs.

Improves energy and alertness (not sedating).

Effective in smoking cessation – dual benefit.



10. Limitations

 Seizure risk limits maximum daily dose to 450 

   mg.

Can worsen anxiety or insomnia in some 

   patients.

 Not suitable for patients with eating disorders 

  or seizure history.



11. Clinical Evidence

Comparable efficacy to SSRIs in depression

   treatment.

 FDA-approved for smoking cessation and 

   highly effective in reducing relapse.

Patients report better energy, motivation, 

   and sexual functioning compared to SSRIs.



✅ Conclusion:

BUPACURE is a unique and versatile antidepressant that improves mood, helps patients quit smoking, and has advantages like less weight gain, less sedation, and fewer sexual side effects. However, it must be used with caution due to the risk of seizures and contraindications in certain populations.